The Complexity of the cGAS-STING Pathway in CNS Pathologies
Open Access
- 9 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 15
Abstract
Neuroinflammation driven by type-I interferons in the CNS is well established to exacerbate the progression of many CNS pathologies both acute and chronic. The role of adaptor protein Stimulator of Interferon Genes (STING) is increasingly appreciated to instigate type-I IFN-mediated neuroinflammation. As an upstream regulator of type-I IFNs, STING modulation presents a novel therapeutic opportunity to mediate inflammation in the CNS. This review will detail the current knowledge of protective and detrimental STING activity in acute and chronic CNS pathologies and the current therapeutic avenues being explored.Keywords
This publication has 113 references indexed in Scilit:
- Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STINGMolecular Cell, 2013
- Role of type I interferons in inflammasome activation, cell death, and disease during microbial infectionFrontiers in Cellular and Infection Microbiology, 2013
- STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling PathwayScience Signaling, 2012
- STING is a direct innate immune sensor of cyclic di-GMPNature, 2011
- AMP-activated protein kinase—an energy sensor that regulates all aspects of cell functionGenes & Development, 2011
- Type I Interferons Mediate the Innate Cytokine Response to Recombinant Fowlpox Virus but Not the Induction of Plasmacytoid Dendritic Cell-Dependent Adaptive ImmunityJournal of Virology, 2010
- STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunityNature, 2009
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signallingNature, 2008
- How dying cells alert the immune system to dangerNature Reviews Immunology, 2008
- Phenotype and Course of Hutchinson–Gilford Progeria SyndromeNew England Journal of Medicine, 2008